
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Trajectories of prediagnostic functioning in Parkinson’s disease
Sirwan K.L. Darweesh, Vincentius J.A. Verlinden, Bruno H. Stricker, et al.
Brain (2016) Vol. 140, Iss. 2, pp. 429-441
Open Access | Times Cited: 158
Sirwan K.L. Darweesh, Vincentius J.A. Verlinden, Bruno H. Stricker, et al.
Brain (2016) Vol. 140, Iss. 2, pp. 429-441
Open Access | Times Cited: 158
Showing 1-25 of 158 citing articles:
The Rotterdam Study: 2018 update on objectives, design and main results
M. Arfan Ikram, Guy Brusselle, Sarwa Darwish Murad, et al.
European Journal of Epidemiology (2017) Vol. 32, Iss. 9, pp. 807-850
Open Access | Times Cited: 416
M. Arfan Ikram, Guy Brusselle, Sarwa Darwish Murad, et al.
European Journal of Epidemiology (2017) Vol. 32, Iss. 9, pp. 807-850
Open Access | Times Cited: 416
Objectives, design and main findings until 2020 from the Rotterdam Study
M. Arfan Ikram, Guy Brusselle, Mohsen Ghanbari, et al.
European Journal of Epidemiology (2020) Vol. 35, Iss. 5, pp. 483-517
Open Access | Times Cited: 397
M. Arfan Ikram, Guy Brusselle, Mohsen Ghanbari, et al.
European Journal of Epidemiology (2020) Vol. 35, Iss. 5, pp. 483-517
Open Access | Times Cited: 397
Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study
Seyed‐Mohammad Fereshtehnejad, Chun Yao, Amélie Pelletier, et al.
Brain (2019) Vol. 142, Iss. 7, pp. 2051-2067
Open Access | Times Cited: 294
Seyed‐Mohammad Fereshtehnejad, Chun Yao, Amélie Pelletier, et al.
Brain (2019) Vol. 142, Iss. 7, pp. 2051-2067
Open Access | Times Cited: 294
Prodromal Parkinson disease subtypes — key to understanding heterogeneity
Daniela Berg, Per Borghammer, Seyed‐Mohammad Fereshtehnejad, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 6, pp. 349-361
Closed Access | Times Cited: 272
Daniela Berg, Per Borghammer, Seyed‐Mohammad Fereshtehnejad, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 6, pp. 349-361
Closed Access | Times Cited: 272
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 157
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come
Ronald B. Postuma, Daniela Berg
Movement Disorders (2019) Vol. 34, Iss. 5, pp. 665-675
Closed Access | Times Cited: 154
Ronald B. Postuma, Daniela Berg
Movement Disorders (2019) Vol. 34, Iss. 5, pp. 665-675
Closed Access | Times Cited: 154
Clinical and imaging evidence of brain-first and body-first Parkinson's disease
Jacob Horsager, Karoline Knudsen, Michael Sommerauer
Neurobiology of Disease (2022) Vol. 164, pp. 105626-105626
Open Access | Times Cited: 96
Jacob Horsager, Karoline Knudsen, Michael Sommerauer
Neurobiology of Disease (2022) Vol. 164, pp. 105626-105626
Open Access | Times Cited: 96
Wearable movement-tracking data identify Parkinson’s disease years before clinical diagnosis
Ann‐Kathrin Schalkamp, Kathryn J. Peall, Neil A. Harrison, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2048-2056
Open Access | Times Cited: 79
Ann‐Kathrin Schalkamp, Kathryn J. Peall, Neil A. Harrison, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2048-2056
Open Access | Times Cited: 79
A Cortical Pathogenic Theory of Parkinson’s Disease
Guglielmo Foffani, José Á. Obeso
Neuron (2018) Vol. 99, Iss. 6, pp. 1116-1128
Open Access | Times Cited: 137
Guglielmo Foffani, José Á. Obeso
Neuron (2018) Vol. 99, Iss. 6, pp. 1116-1128
Open Access | Times Cited: 137
The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Daniel Weintraub, Eugenia Mamikonyan
American Journal of Geriatric Psychiatry (2019) Vol. 27, Iss. 9, pp. 998-1018
Open Access | Times Cited: 130
Daniel Weintraub, Eugenia Mamikonyan
American Journal of Geriatric Psychiatry (2019) Vol. 27, Iss. 9, pp. 998-1018
Open Access | Times Cited: 130
Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort
Seyed‐Mohammad Fereshtehnejad, Jacques Montplaisir, Amélie Pelletier, et al.
Movement Disorders (2017) Vol. 32, Iss. 6, pp. 865-873
Closed Access | Times Cited: 117
Seyed‐Mohammad Fereshtehnejad, Jacques Montplaisir, Amélie Pelletier, et al.
Movement Disorders (2017) Vol. 32, Iss. 6, pp. 865-873
Closed Access | Times Cited: 117
Clinical and Imaging Markers of Prodromal Parkinson's Disease
Eldbjørg Hustad, Jan Aasly
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 111
Eldbjørg Hustad, Jan Aasly
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 111
Cognitive changes in prodromal Parkinson's disease: A review
Sophie Fengler, Inga Liepelt‐Scarfone, Kathrin Brockmann, et al.
Movement Disorders (2017) Vol. 32, Iss. 12, pp. 1655-1666
Closed Access | Times Cited: 104
Sophie Fengler, Inga Liepelt‐Scarfone, Kathrin Brockmann, et al.
Movement Disorders (2017) Vol. 32, Iss. 12, pp. 1655-1666
Closed Access | Times Cited: 104
Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations
Anette Schrag, Zacharias Anastasiou, Gareth Ambler, et al.
Movement Disorders (2019) Vol. 34, Iss. 4, pp. 480-486
Open Access | Times Cited: 95
Anette Schrag, Zacharias Anastasiou, Gareth Ambler, et al.
Movement Disorders (2019) Vol. 34, Iss. 4, pp. 480-486
Open Access | Times Cited: 95
Sleep and risk of parkinsonism and Parkinson’s disease: a population-based study
Thom S. Lysen, Sirwan K.L. Darweesh, M. Kamran Ikram, et al.
Brain (2019) Vol. 142, Iss. 7, pp. 2013-2022
Open Access | Times Cited: 81
Thom S. Lysen, Sirwan K.L. Darweesh, M. Kamran Ikram, et al.
Brain (2019) Vol. 142, Iss. 7, pp. 2013-2022
Open Access | Times Cited: 81
Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors
Paulina González-Latapí, Ece Bayram, Irene Litvan, et al.
Behavioral Sciences (2021) Vol. 11, Iss. 5, pp. 74-74
Open Access | Times Cited: 69
Paulina González-Latapí, Ece Bayram, Irene Litvan, et al.
Behavioral Sciences (2021) Vol. 11, Iss. 5, pp. 74-74
Open Access | Times Cited: 69
Prodromal Parkinson's disease: hype or hope for disease-modification trials?
Philipp Mahlknecht, Kathrin Marini, Mario Werkmann, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 47
Philipp Mahlknecht, Kathrin Marini, Mario Werkmann, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 47
Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
Marc Cárceles-Cordon, Dan Weintraub, Alice Chen‐Plotkin
Neuron (2023) Vol. 111, Iss. 10, pp. 1531-1546
Open Access | Times Cited: 26
Marc Cárceles-Cordon, Dan Weintraub, Alice Chen‐Plotkin
Neuron (2023) Vol. 111, Iss. 10, pp. 1531-1546
Open Access | Times Cited: 26
α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes
Emmanouela Leandrou, Ioanna Chalatsa, Dimitrios Anagnostou, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Emmanouela Leandrou, Ioanna Chalatsa, Dimitrios Anagnostou, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Long-Term Dementia Risk in Parkinson Disease
Julia Gallagher, Caroline Gochanour, Chelsea Caspell‐Garcia, et al.
Neurology (2024) Vol. 103, Iss. 5
Open Access | Times Cited: 9
Julia Gallagher, Caroline Gochanour, Chelsea Caspell‐Garcia, et al.
Neurology (2024) Vol. 103, Iss. 5
Open Access | Times Cited: 9
Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the art
Jules M. Janssen Daalen, Robin van den Bergh, Eva M. Prins, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 8
Jules M. Janssen Daalen, Robin van den Bergh, Eva M. Prins, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 8
Biological effects of pathologies in Lewy body diseases: why timing matters
Elie Matar, Glenda M. Halliday
The Lancet Neurology (2025) Vol. 24, Iss. 5, pp. 441-455
Closed Access | Times Cited: 1
Elie Matar, Glenda M. Halliday
The Lancet Neurology (2025) Vol. 24, Iss. 5, pp. 441-455
Closed Access | Times Cited: 1
Cognition and the course of prodromal Parkinson's disease
Daniel Weintraub, Lana M. Chahine, Keith A. Hawkins, et al.
Movement Disorders (2017) Vol. 32, Iss. 11, pp. 1640-1645
Open Access | Times Cited: 80
Daniel Weintraub, Lana M. Chahine, Keith A. Hawkins, et al.
Movement Disorders (2017) Vol. 32, Iss. 11, pp. 1640-1645
Open Access | Times Cited: 80
Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment
Jennifer G. Goldman, Samantha K. Holden, Irene Litvan, et al.
Movement Disorders (2018) Vol. 33, Iss. 4, pp. 503-510
Open Access | Times Cited: 72
Jennifer G. Goldman, Samantha K. Holden, Irene Litvan, et al.
Movement Disorders (2018) Vol. 33, Iss. 4, pp. 503-510
Open Access | Times Cited: 72
Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism
Sirwan K.L. Darweesh, Frank J. Wolters, Ronald B. Postuma, et al.
JAMA Neurology (2017) Vol. 74, Iss. 12, pp. 1431-1431
Open Access | Times Cited: 64
Sirwan K.L. Darweesh, Frank J. Wolters, Ronald B. Postuma, et al.
JAMA Neurology (2017) Vol. 74, Iss. 12, pp. 1431-1431
Open Access | Times Cited: 64